If your goal is weight loss, you’re looking for Wegovy, not Ozempic. Both contain semaglutide, but Wegovy is FDA-approved for weight management. General eligibility: BMI of 30+ (or 27+ with a weight-related condition like high blood pressure, sleep apnea, or high cholesterol). Schedule a consultation to find out if you qualify.
The short version
Most people searching “am I a candidate for Ozempic” are actually asking whether they qualify for semaglutide-based weight loss. The answer depends on your BMI, health history, and insurance — but not on Ozempic specifically. For weight loss, the right semaglutide product is Wegovy.
Ozempic eligibility (for diabetes)
Ozempic is FDA-approved for adults with type 2 diabetes as an adjunct to diet and exercise. You are a candidate for Ozempic if:
- You have a confirmed type 2 diabetes diagnosis
- Your A1C needs improvement beyond what diet, exercise, and metformin achieve
- Your prescriber determines semaglutide is appropriate for your glycemic management
If you don’t have type 2 diabetes, Ozempic is not the right medication for you — regardless of weight loss goals.
Wegovy eligibility (for weight loss)
If weight management is your goal, Wegovy is the FDA-approved semaglutide option. You may be a candidate if:
- BMI of 30 or higher (obesity), or
- BMI of 27 or higher with at least one weight-related condition such as:
- High blood pressure (hypertension)
- Type 2 diabetes or prediabetes
- High cholesterol (dyslipidemia)
- Obstructive sleep apnea
- Heart disease or cardiovascular risk factors
Additional considerations include your medical history, current medications, and ability to commit to the broader program (nutrition, activity, ongoing clinical follow-up).
Use our BMI calculator for a quick estimate. Keep in mind that BMI is one screening tool — your clinician evaluates the full picture, including body composition, metabolic markers, and health history.
Who should not take semaglutide
Semaglutide (Ozempic or Wegovy) is not appropriate for patients with:
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Known hypersensitivity to semaglutide or any component
- History of pancreatitis (requires careful evaluation)
- Pregnancy or plans to become pregnant within 2 months
Your clinician will review your full medical history to ensure semaglutide is safe and appropriate for you.
Next steps
If you think you may qualify for semaglutide-based weight management:
- Schedule a consultation at PEAK. We evaluate your health history, BMI, and goals.
- We verify your insurance. Before your first visit, we check whether Wegovy (or Zepbound) is covered under your plan.
- Your clinician recommends a plan. This includes medication selection, titration schedule, and support resources (nutrition counseling, monitoring).
You don’t need a referral (except TRICARE Prime active-duty members, who require a referral through their chain of command). You don’t need to have tried other diets first (though prior attempts may support insurance approval). You just need to get started.
